Literature DB >> 35418773

Early Prediction Model of Acute Aortic Syndrome Mortality in Emergency Departments.

Daidai Wang1, Hua Zhang2, Lanfang Du1, Qiangrong Zhai1, Guangliang Hu1, Wei Gao1, Anyi Zhang1, Sa Wang1, Yajuan Hao1, Kaijian Shang1,3, Xueqing Liu1, Yanxia Gao4, Nijiati Muyesai5, Qingbian Ma1.   

Abstract

Purpose: Acute aortic syndrome is a constellation of life-threatening medical conditions for which rapid assessment and targeted intervention are important for the prognosis of patients who are at high risk of in-hospital death. The current study aims to develop and externally validate an early prediction mortality model that can be used to identify high-risk patients with acute aortic syndrome in the emergency department. Patients and
Methods: This retrospective multi-center observational study enrolled 1088 patients with acute aortic syndrome admitted to the emergency departments of two hospitals in China between January 2017 and March 2021 for model development. A total of 210 patients with acute aortic syndrome admitted to the emergency departments of Peking University Third Hospital between January 2007 and December 2021 was enrolled for model validation. Demographics and clinical factors were collected at the time of emergency department admission. The predictive variables were determined by referring to the results of previous studies and the baseline analysis of this study. The study's endpoint was in-hospital death. To assess internal validity, we used a fivefold cross-validation method. Model performance was validated internally and externally by evaluating model discrimination using the area under the receiver-operating characteristic curve (AUC). A nomogram was developed based on the binary regression results.
Results: In the development cohort, 1088 patients with acute aortic syndromes were included, and 88 (8.1%) patients died during hospitalization. In the validation cohort, 210 patients were included, and 20 (9.5%) patients died during hospitalization. The final model included the following variables: digestive system symptoms (OR=2.25; P=0.024), any pulse deficit (OR=7.78; P<0.001), creatinine (µmol/L)(OR=1.00; P=0.018), lesion extension to iliac vessels (OR=4.49; P<0.001), pericardial effusion (OR=2.67; P=0.008), and Stanford type A (OR=10.46; P<0.001). The model's AUC was 0.838 (95% CI 0.784-0.892) in the development cohort and 0.821 (95% CI 0.750-0.891) in the validation cohort, and the Hosmer-Lemeshow test showed p=0.597. The fivefold cross-validation demonstrated a mean accuracy of 0.94, a mean precision of 0.67, and a mean recall of 0.13.
Conclusion: This risk prediction tool uses simple variables to provide robust prediction of the risk of in-hospital death from acute aortic syndrome and validated well in an independent cohort. The tool can help emergency clinicians quickly identify high-risk acute aortic syndrome patients, although further studies are needed for verifying the prospective data and the results of our study.
© 2022 Wang et al.

Entities:  

Keywords:  acute aortic syndrome; emergency department; risk prediction model

Year:  2022        PMID: 35418773      PMCID: PMC8995175          DOI: 10.2147/IJGM.S357910

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Acute aortic syndrome (AAS) is a constellation of life-threatening medical conditions, including classic acute aortic dissection (AAD), intramural hematoma (IMH), penetrating atherosclerotic aortic ulcer (PAU), and even thoracic aortic rupture. They share common pathophysiological pathways, specifically the breakdown of the intima and media, common clinical characteristics, and present diagnostic and therapeutic challenges.1–3 Emergency physicians need a simple and accessible tool to identify patients suffering from AAS who are at high risk of in-hospital mortality, thereby helping them make medical decisions and allocate resources for high-risk patients as soon as possible.4 Making use of such a tool would also help patients’ families understand the severity of the disease so they can make quicker and better decisions for their family member. Several AAS prediction models have already been developed and published,5–8 but most of them cannot be easily applied by emergency physicians. First, most studies have evaluated the variables of AAD only, rather than the other AAS conditions.6,9 However, acute aortic dissection and intramural hematoma share similar clinical features and complications.10,11 Also, the recognition in recent years that intramural haematoma, or bleeding into the aortic wall, is related to aortic dissection has demonstrated that both conditions can coexist and may constitute a spectrum.10,12 Thus, it is necessary to develop a risk stratification model for AAS. Second, a large proportion of existing models are based on surgery, which is less useful in the emergency department (ED).9,13 Third, some of the identified predictors need a manual assessment process, such as false lumen/true lumen of ascending aorta ≥0.75,4 which can be too time consuming for emergency physicians. Our objective was to develop and validate a practical risk stratification approach that could be used to identify AAS patients’ in-hospital mortality in the emergency department.

Methods

Patient Selection

This study uses two datasets: a development and a validation set. The development dataset was derived from The First Affiliated Hospital of Zhengzhou University and Xinjiang Ulger Municipal People’s Hospital. The validation database was derived from Peking University Third Hospital. This retrospective cohort study enrolled patients diagnosed with AAS who admitted to the emergency departments of The First Affiliated Hospital of Zhengzhou University and Xinjiang Ulger Municipal People’s Hospital between January 2017 and March 2021 for model development. Patients with AAS admitted to the emergency departments of Peking University Third Hospital between January 2007 and December 2021 were enrolled for model validation. Inclusion criteria for both cohorts were patients who were diagnosed with AAD, IMH, or PAU by computed tomography angiography and/or transthoracic echocardiography. Exclusion criteria were: 1) >14 days from onset of symptoms, 2) patient under 18 years old, 3) presence of traumatic or iatrogenic acute aortic syndrome, 4) acute aortic syndrome in pregnancy, 5) missing data relevant to the analysis.

Data Collection Measures

The research team worked with senior clinicians and statisticians to design our comprehensive registry, which consists of five parts: demographic characteristics, medical history, laboratory examinations, imaging studies, and in-hospital outcome. The registry was designed and implemented on the Research Electronic Data Capture (REDCap) v 11.1.0 platform, which provides an intuitive interface for validated data entry and audit trails to track the history of data entry and revision.14 Data were collected by ED staff from electronic medical records and was entered into the REDcap by research staff. All of them have undergone unified training to ensure consistency in the data entry process. Each research center has a research director who check the entered data regularly. The entered data included the patient demographics (including age, gender and diagnosis); medical history (including etiology and history); clinical presentation; physical findings; laboratory examinations and imaging studies that were collected at the time of ED admission. The endpoint event was in-hospital death. The follow-up was carried out at discharge. Acute aortic dissection is defined as a separation of the layers of the aortic wall due to an intimal tear; IMH is defined as a hematoma confined within the medial layer of the aorta in the absence of a detectable intimal tear; PAU is defined as a contained aortic rupture due to slow oozing from the damaged aorta at or near the site of aortic lesion; In-hospital mortality was defined as death occurring before hospital discharge.

Statistical Analysis

Study data were managed as well as collected using REDCap electronic data capture tools hosted at the National Institute of Health Data Science of Peking University. Patients included in the study were divided into the survivor group and the non-survivor group. Data were described using mean ± standard deviation or median (25th–75th percentiles) for continuous variables; frequencies and proportions were used for categorical variables. Denominators represent only fully reported cases; cases with missing data were not included. The student’s t-test was used to compare normally distributed continuous variables, while the Mann–Whitney U-test was used for non-normally distributed continuous variables. Categorical variables were analyzed using by a χ2 test and Fisher exact test, when appropriate. Binary logistic regression analysis was used to build an early prediction model. In-hospital death was taken as the dependent variable, and the predictive variables were determined by referring to the results of previous studies and the baseline analysis of this study. When an independent variable was a categorical variable, the minimum value group was taken as the reference group. When an independent variable was a continuous variable, it was directly included into the binary logistic regression model. The fivefold cross-validation method was used to calculate and verify its accuracy, precision, recall, and F-measure. Model performance was validated internally and externally by evaluating model discrimination using the area under the receiver-operating characteristic curve (AUC). To facilitate the application of the model, we drew a nomogram according to the coefficients of the regression model. A p-value<0.05 was considered statistically significant. Data analysis was performed with the use of IBM SPSS statistics software (v25, IBM, New York, USA) and R software (v4.0.3, Vienna, Austria).

Ethical Approval

The study conformed to the Declaration of Helsinki. This study was a multi-center cohort study and the leading research center of this study was Peking University Third Hospital. The study was approved by the institutional review board of Peking University Third Hospital and all participating hospitals (M2020410, Peking University Third Hospital Medical Science Research Ethics Committee). The informed consent requirement was waived for the following reasons: a. This study was a retrospective analysis of medical records, involving no potential risk. b. All Data was anonymous.

Results

Patient Characteristics

A total of 1088 patients with acute aortic syndromes were included in the development cohort. Among them, 88 (8.1%) patients died during hospitalization. About 62.9% of patients were Stanford type A. Most of them were middle-aged men, with a male predominance of 77.2%. For the validation cohort, 210 patients were included. Among them, 20 (9.5%) patients died during hospitalization. About 41.4% of patients were Stanford type A. Most of them were middle-aged men, with a male predominance of 79.0%. Patients’ characteristics of both cohorts are shown in Table 1.
Table 1

Baseline Clinical Characteristics of All Patients with AAS

VariableDevelopment CohortValidation Cohort
SurvivorsNon-SurvivorsSurvivorsNon-Survivors
N (%)1000 (91.9%)88 (8.1%)190 (90.5%)20 (9.5%)
Demographics
 Age, y52.0 [45.0–62.0]51.0 [43.0–58.0]51.9±14.160.9±13.0*
 Male774 (77.4%)66 (75.0%)153 (80.5%)13 (65.0%)
Stanford type
 Type A603 (60.3%)82 (93.2%)*70 (36.8%)17 (85.0%)*
 Type B397 (39.7%)6 (6.8%)120 (63.2%)3 (15.0%)
Clinical type
 AAD901 (90.1%)87 (98.9%)*174 (91.6%)20 (100%)
 IMH85 (8.5%)1 (1.1%)16 (8.42%)0 (0.00%)
 PAU14 (1.4%)0 (0.0%)0 (0.0%)0 (0.00%)
Etiology and history
 Marfan syndrome9 (0.9%)0 (0.0%)3 (1.58%)0 (0.00%)
 Biscuspid aortic valve5 (0.5%)2 (2.3%)1 (0.53%)0 (0.00%)
 Aortic aneurysm5 (0.5%)1 (1.1%)3 (1.58%)3 (1.58%)
 Hypertension736 (73.9%)68 (77.3%)121 (63.7%)14 (70.0%)
 Diabetes39 (3.9%)4 (4.6%)4 (2.11%)2 (10.0%)
 Coronary heart disease50 (5.0%)6 (6.9%)*14 (7.37%)3 (15.0%)
 Chronic renal insufficiency26 (2.6%)3 (3.4%)*8 (4.21%)1 (5.00%)
 Prior cardiac surgery12 (1.2%)1 (1.1%)0 (0%)0 (0%)
Clinical presentations and signs
 Chest pain778 (77.8%)78 (88.6%)*92 (48.4%)14 (70.0%)
 Back pain696 (69.6%)68 (77.3%)74 (38.9%)9 (45.0%)
  Abdominal pain200 (20.0%)29 (33.0%)*70 (36.8%)6 (30.0%)
  Abrupt pain946 (98.8%)84 (98.4%)188 (98.9%)19 (95.0%)
 Palpitation193 (19.3%)30 (34.1%)*8 (4.21%)3 (15.0%)
 Sweating389 (38.9%)57 (64.8%)*61 (32.1%)11 (55.0%)
 Dyspnea173 (17.3%)29 (33.0%)*24 (12.6%)3 (15.0%)
 Digestive system symptoms431 (43.1%)54 (61.4%)*39 (20.5%)9 (45.0%)*
 Central nervous system symptoms117 (11.7%)17 (19.3%)*14 (7.37%)8 (40.0%)*
 Limb involved symptoms84 (8.4%)13 (14.8%)*18 (9.47%)4 (20.0%)
 Mean SBP, mm Hg147 [129–164]134 [112–163]*155±35.2128±43.0*
 Any pulse deficit52 (5.2%)19 (21.8%)*11 (5.79%)2 (10.0%)
Laboratory data
 White blood cell count (109/L)11.5 [9.09–14.1]13.2 [10.7–17.8]*11.4 [9.03–14.6]13.8 [11.1–19.8]*
 Neutrophil count (109/L)9.78 [7.31–12.4]11.5 [9.54–15.4]*9.15 [6.20–12.6]11.8 [8.06–17.3]*
 Lymphocyte count (109/L)0.94 [0.67–1.32]0.99 [0.73–1.33]1.52±1.021.75±1.13
 Platelet (1012/L)178 [143–220]180 [143–212]189 [156–226]168 [133–187]
 Hemoglobin (g/L)135 [122–146]140 [124–153]138±23.4129±20.6
 Total bilirubin (umol/L)14.9 [10.9–20.9]18.5 [14.5–27.3]*16.8 [11.8–23.9]13.1 [9.05–22.5]
 Creatinine (umol/L)76.0 [62.2–96.0]97.6 [68.5–141]*83.0 [66.0–110]97.0 [80.0–127]
 PT (s)12.6 [11.1–14.2]14.7 [13.7–16.4]*11.6 [10.8–12.4]12.1 [11.5–13.1]*
 APTT (s)32.3 [28.4–38.3]38.7 [36.1–42.3]*30.7 [28.2–34.6]30.0 [28.1–31.7]
 INR1.05 [0.99–1.13]1.15 [1.09–1.34]*1.07 [1.01–1.15]1.12 [1.07–1.22]*
 D-dimer (µg/mL)2.60 [1.02–6.96]8.73 [4.78–13.9]*2.02 [0.80–6.04]9.60 [3.33–27.2]*
Aortic CT angiography
 Branch vessel involvement
  Coronary artery involvement20 (2.3%)2 (2.8%)3 (1.58%)2 (10.0%)
  Brachiocephalic trunk involvement90 (10.5%)14 (19.7%)*21 (11.1%)7 (35.0%)*
  Celiac trunk involvement118 (13.8%)14 (19.7%)118 (13.8%)14 (19.7%)
  Renal artery involvement158 (18.4%)18 (25.4%)158 (18.4%)18 (25.4%)
 Lesion extension to iliac vessels214 (24.9%)32 (44.4%)*67 (7.81%)5 (7.04%)
 Abdominal organ involvement196 (22.8%)27 (38.0%)196 (22.8%)27 (38.0%)*
 Pleural effusion260 (33.4%)15 (26.3%)260 (30.3%)15 (21.1%)
 Pericardial effusion123 (15.6%)22 (37.9%)125 (14.6%)22 (31.0%)*

Note: *p<0.05.

Abbreviations: AAD, acute aortic dissection; IMH, intramural hematoma; PAU, penetrating atherosclerotic aortic ulcer; AAS, acute aortic syndromes; ED, emergency department; SBP, systolic blood pressure; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalised ratio.

Baseline Clinical Characteristics of All Patients with AAS Note: *p<0.05. Abbreviations: AAD, acute aortic dissection; IMH, intramural hematoma; PAU, penetrating atherosclerotic aortic ulcer; AAS, acute aortic syndromes; ED, emergency department; SBP, systolic blood pressure; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalised ratio.

Univariate Predictors of in-Hospital Death for Patients with AAS in Emergency Departments

In the development cohort, clinical characteristics that showed significant association with in-hospital mortality included chest pain, abdominal pain, palpitation, sweating, dyspnea, digestive system symptoms, central nervous system symptoms, limb involved symptoms, mean systolic blood pressure, mean diastolic blood pressure, and any pulse deficit. Patients whose laboratory examinations showed higher levels of white blood cell count, neutrophil count, total bilirubin, creatinine, prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), and D-dimer were additionally associated with higher in-hospital mortality. Also, some CT angiography signs differ significantly between survivors and non-survivors, including brachiocephalic trunk involvement, lesion extension to iliac vessels, abdominal organ involvement (any degree), and pericardial effusion (Table 1). In the Peking University Third hospital validation cohort, clinical characteristics that showed significant association with in-hospital mortality included digestive system symptoms, central nervous system symptoms, mean systolic blood pressure. Patients whose laboratory examinations showed higher levels of white blood cell count, neutrophil count, prothrombin time (PT), international normalized ratio (INR), and D-dimer were additionally associated with higher in-hospital mortality. Also, some CT angiography signs differ significantly between survivors and non-survivors, including brachiocephalic trunk involvement, abdominal organ involvement (any degree), and pericardial effusion (Table 1).

Multivariate Predictors for in-Hospital Death in Patients with AAS in Emergency Departments

In the multivariable analysis, the following variables, when present at admission, were shown to be independently associated with increased in-hospital mortality: digestive system symptoms (OR=2.25; P=0.024), any pulse deficit (OR=7.78; P<0.001), creatinine (µmol/L)(OR=1.00; P=0.018), lesion extension to iliac vessels (OR=4.49; P<0.001), pericardial effusion (OR=2.67; P=0.008), and Stanford type A (OR=10.46; P<0.001) (Table 2). The AUC (C-index) was 0.838 (95% CI 0.784–0.892) using these multivariate predictors (Figure 1A). The Hosmer-Lemeshow results indicated a significant level of goodness of fit for the logistic regression model (χ2 =6.45, p=0.597) (Figure 1B). We conducted a fivefold cross-validation, which demonstrated a mean accuracy of 0.94, a mean precision of 0.67, and a mean recall of 0.13.
Table 2

Multivariate Logistic Regression of Predictive Variables with In-Hospital Death

VariableUnivariate AnalysisMultivariate Analysis
pOR (95% CI)pOR (95% CI)
Digestive system symptoms0.0012.10[1.34,3.28]0.0242.25[1.11,4.53]
Any pulse deficit<0.0015.07[2.84,9.06]<0.0017.78[2.94,20.63]
Creatinine (µmol/L)<0.0011.00[1.00,1.00]0.0181.00[1.00,1.00]
Lesion extension to iliac vessels<0.0012.41[1.48,3.93]<0.0014.49[2.33,8.64]
Pericardial effusion<0.0013.31[1.88,5.82]0.0082.67[1.29,5.53]
Stanford type A<0.0019.00[3.89,20.81]<0.00110.46[3.31,33.1]

Abbreviations: Cr, creatinine; CI, confidence interval; OR, odds ratio.

Figure 1

(A) ROC of the model: the AUC (C index) was 0.838 (95% range 0.784–0.892). (B) Calibration curves for the prediction model.

Multivariate Logistic Regression of Predictive Variables with In-Hospital Death Abbreviations: Cr, creatinine; CI, confidence interval; OR, odds ratio. (A) ROC of the model: the AUC (C index) was 0.838 (95% range 0.784–0.892). (B) Calibration curves for the prediction model.

Validation of Predictive Model for in-Hospital Mortality in Patients with AAS

External validation resulted in an AUC of 0.821 (95% CI 0.750–0.891). The external validation indicates a good discriminative capacity of the model (Figure 2).
Figure 2

ROC of the model in validation cohort: the AUC (C index) was 0.821 (95% range 0.750–0.891).

ROC of the model in validation cohort: the AUC (C index) was 0.821 (95% range 0.750–0.891).

Nomogram for Bedside Application

Based on these multivariable regression results, a nomogram for bedside application was established (Figure 3).
Figure 3

In the nomogram for bedside application, we assigned values to each of the variables based on the multivariable regression results. To use this nomogram, first locate whether the patient has any pulse deficit, then draw a line straight up to the Points axis on the top to obtain the score associated with pulse deficit. Repeat the process for the other covariates (from age to Stanford type A). Add the scores of the covariates together and locate the total score on the Total Points axis just below the last covariate. Next, draw a line straight down to the Risk of Death axis at the bottom to obtain the probability.

In the nomogram for bedside application, we assigned values to each of the variables based on the multivariable regression results. To use this nomogram, first locate whether the patient has any pulse deficit, then draw a line straight up to the Points axis on the top to obtain the score associated with pulse deficit. Repeat the process for the other covariates (from age to Stanford type A). Add the scores of the covariates together and locate the total score on the Total Points axis just below the last covariate. Next, draw a line straight down to the Risk of Death axis at the bottom to obtain the probability.

Discussion

Developed on the basis of routinely collected and easily available clinical information, our model was demonstrated to be an effective tool for the early prediction of the in-hospital mortality rate of AAS in its initial phase after ED arrival. Digestive system symptoms, any pulse deficit, creatinine, lesion extension to iliac vessels, pericardial effusion, and Stanford type A accurately and pragmatically predicted the risk of in-hospital death. The AUC of 0.838 and showed the model had overall good discrimination in identifying patients at risk. Also, it validated well in an independent cohort. Compared with previous models, our binary logistic regression model has several strengths. First, our predictor variables can be acquired quickly and effectively at the time of ED admission, making it feasible for early identification of patients at high risk of in-hospital death in the ED. Also, the model has only six variables, and they do not require mathematical manipulation, making it easy for emergency clinicians to use. Some studies have proposed prediction models that have also shown strong discrimination, but they have used more variables, which makes the models less efficient.15,16 Second, our study has a large sample size, with 1088 patients involved, larger, as far as we can determine, than most other studies. Recently, a systematic review of prediction models for acute aortic dissection concluded that the sample size varied from 35 to 1034 (median 165, IQR,103–348).17 Tolenaar et al used multinational data from the International Registry of Acute Aortic Dissection (IRAD) that involved 1034 patients, but their aim was to investigate predictors of mortality among patients presenting with acute type B aortic dissection.6 Czerny et al developed the German Registry of Acute Aortic Dissection Type A (GERAADA) score with 2537 patients involved, but the endpoint of their study was the 30-day mortality rate, and the patients who were diagnosed all underwent surgery, which is not suitable to use in ED.9 Third, our study focuses exclusively on unselected consecutive patients admitted to the emergency department, whereas the currently existing models target patients already admitted to various wards, such as cardiac surgery.9,15 Patients admitted to the ED may die before they are admitted to specific wards, or they may refuse to be admitted to those wards, or they may be transferred to other hospitals. Consequently, the group of patients admitted to emergency departments is more heterogeneous, making it more challenging for the model to achieve accurate predictions based on particular wards. For these reasons, our study can be generalized to all patients with AAS presenting at the emergency department regardless of their clinical status or treatment strategy. The model’s six variables are digestive system symptoms, any pulse deficit, creatinine (µmol/L), lesion extension to iliac vessels, pericardial effusion, and Stanford type A. It is not surprising that Stanford type A is associated with worse outcomes, which had been demonstrated by many previous studies.18,19 Pericardial effusion has also been shown to be a predictive variable in previous studies.20 According to some studies, pericardial effusion may result from rupture of the thoracic aorta into the pericardial cavity or from the transudation of fluid into the pericardial cavity through the intact wall of the false lumen.21,22 Several studies have shown that the presence of any pericardial effusion is an ominous sign.22,23 More importantly, our study shows that digestive system symptoms, any pulse deficit, lesion extension to iliac vessels, and creatinine confer an even higher mortality rate. These findings may have therapeutic implications, as these four predictors are associated with malperfusion syndrome (MPS). Several studies have shown that AAS patients with MPS have poorer clinical outcomes.24–26 MPS can affect any vascular bed, with mesenteric malperfusion being the most challenging, as it is associated with a three to fourfold increase in mortality in both acute type A and B aortic dissections.27 Ischemic damage of malperfused organs should be minimized by restoring perfusion as early as possible in order to improve surgical outcomes.24 The presence of these predictors in our model can help emergency physicians with early identification of potential MPS, which may help improve prognosis of these patients. If patients have these clinical manifestations on presentation, physicians need to attempt to find whether and which vessels may have been affected, such as mesenteric, renal, or limb. Identifying these vessels will help physicians find potential MPS quickly and relieve organ ischemia in a timely fashion, either through surgery or by percutaneous techniques. With the development of technique in medical diagnosis, we can add some novel variable, such as the change in blood hemodynamics which can be detected in CTA using the technique of computational fluid dynamic technique, in our model to identify patients with MPS in the future.28,29 This study additionally established a nomogram for bedside application, which has implications for the education of the patient’s family and for clinical practices. As the nomogram can be readily understood, patients with acute aortic syndromes and their relatives can obtain reliable information without needing to depend on their physician’s descriptions of the prognosis of this acutely devastating condition, thereby helping them to realize the severity of the disease quickly and participate effectively in shared decision making. Making appropriate decisions quickly can help emergency physicians manage the disease effectively, such as consulting with the surgeon as soon as possible; surgery must be started quickly, as it may be critical for improving the outcome of patients suffering from type A acute aortic syndrome.30,31

Limitations

This study has several limitations. First, the design is a two-center retrospective study and therefore subject to selection bias, information bias, and other confounders. Second, the model was externally validated only in one independent hospital, and the model needs to be validated in more independent population, so additional studies are needed to evaluate our predictive model and risk assessment tool.

Conclusions

In our study, the risk factors for preoperative mortality were analyzed in patients with acute aortic syndromes who visited emergency departments, and a simple and effective risk assessment method was established to help emergency clinicians quickly identify high-risk patients and make appropriate medical decisions.
  30 in total

1.  The Strongest Risk Factor for Operative Mortality in Acute Type A Aortic Dissection is Acidosis: Validation of Risk Model.

Authors:  Chin Siang Ong; Lucy Nam; Pooja Yesantharao; Jie Dong; Joseph K Canner; Roald J Teuben; Xun Zhou; Allen Young; Alejandro Suarez-Pierre; Michael K Pasque; Jennifer S Lawton
Journal:  Semin Thorac Cardiovasc Surg       Date:  2020-02-24

2.  Outcome Predictors in Patients Presenting With Acute Aortic Dissection.

Authors:  Chen Lingzhi; Zhou Hao; Huang Weijian; Zheng Gaoshu; Sun Chengchao; Chen Changxi; Zhao Chuhuan; Gao Zhan
Journal:  J Cardiothorac Vasc Anesth       Date:  2016-03-31       Impact factor: 2.628

Review 3.  Imaging for acute aortic syndromes.

Authors:  Brett J Carroll; Marc L Schermerhorn; Warren J Manning
Journal:  Heart       Date:  2019-12-10       Impact factor: 5.994

4.  Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score.

Authors:  Vincenzo Rampoldi; Santi Trimarchi; Kim A Eagle; Christoph A Nienaber; Jae K Oh; Eduardo Bossone; Truls Myrmel; Giuseppe M Sangiorgi; Carlo De Vincentiis; Jeanna V Cooper; Jianming Fang; Dean Smith; Thomas Tsai; Arun Raghupathy; Rossella Fattori; Udo Sechtem; Michael G Deeb; Thoralf M Sundt; Eric M Isselbacher
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

Review 5.  Malperfusion syndromes in type A aortic dissection: what we have learned from IRAD.

Authors:  Paolo Berretta; Santi Trimarchi; Himanshu J Patel; Thomas G Gleason; Kim A Eagle; Marco Di Eusanio
Journal:  J Vis Surg       Date:  2018-03-31

Review 6.  Acute Aortic Dissection and Intramural Hematoma: A Systematic Review.

Authors:  Firas F Mussa; Joshua D Horton; Rameen Moridzadeh; Joseph Nicholson; Santi Trimarchi; Kim A Eagle
Journal:  JAMA       Date:  2016-08-16       Impact factor: 56.272

7.  Mesenteric Malperfusion in Acute Aortic Dissection: Challenges and Frontiers.

Authors:  Bashi V Velayudhan; A Mohammed Idhrees; K Mukesh; Ramachandran Nair Kannan
Journal:  Semin Thorac Cardiovasc Surg       Date:  2019-04-10

8.  Presentation, Diagnosis, and Outcomes of Acute Aortic Dissection: 17-Year Trends From the International Registry of Acute Aortic Dissection.

Authors:  Linda A Pape; Mazen Awais; Elise M Woznicki; Toru Suzuki; Santi Trimarchi; Arturo Evangelista; Truls Myrmel; Magnus Larsen; Kevin M Harris; Kevin Greason; Marco Di Eusanio; Eduardo Bossone; Daniel G Montgomery; Kim A Eagle; Christoph A Nienaber; Eric M Isselbacher; Patrick O'Gara
Journal:  J Am Coll Cardiol       Date:  2015-07-28       Impact factor: 24.094

9.  Predicting in-hospital death in patients with type B acute aortic dissection.

Authors:  Jing Zhang; Baoshan Cheng; Mengsi Yang; Jianyuan Pan; Jun Feng; Ziping Cheng
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

10.  Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study.

Authors:  Blessing N R Jaja; Gustavo Saposnik; Hester F Lingsma; Erin Macdonald; Kevin E Thorpe; Muhammed Mamdani; Ewout W Steyerberg; Andrew Molyneux; Airton Leonardo de Oliveira Manoel; Bawarjan Schatlo; Daniel Hanggi; David Hasan; George K C Wong; Nima Etminan; Hitoshi Fukuda; James Torner; Karl L Schaller; Jose I Suarez; Martin N Stienen; Mervyn D I Vergouwen; Gabriel J E Rinkel; Julian Spears; Michael D Cusimano; Michael Todd; Peter Le Roux; Peter Kirkpatrick; John Pickard; Walter M van den Bergh; Gordon Murray; S Claiborne Johnston; Sen Yamagata; Stephan Mayer; Tom A Schweizer; R Loch Macdonald
Journal:  BMJ       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.